Past events

ITD seminar | Journey into sub-Saharan Africa HIV co-infections, TB and CMV

Details Speaker: Dr Matthew Bates, School of Life Sciences, University of Lincoln Hosted by Dr Ursula Gompels Date: Thursday 8 March 2018 Time: 12:45 pm Venue: Manson Lecture Theatre, Keppel Street

UCL-AHRI Symposium: Towards HIV and TB elimination in South Africa

The first UCL-AHRI scientific symposium will take place on 12 February 2018 in the UCL Roberts Building, London. The one-day event entitled, “Towards HIV and TB elimination in South Africa”, will bring together researchers from LSHTM and UCL with those from the African Health Research Institute (AHRI) in South Africa. It will provide a great […]

ITD seminar | Molecular consequences of genomic variation associated with drug resistance in TB and malaria

Summary Genomic studies of Mycobacterium tuberculosis bacteria have revealed loci associated with resistance to anti-tuberculosis drugs. However, the molecular consequences of polymorphism within these candidate loci remain poorly understood. The talk will summarise the development and findings of a new computational protocol to quantify the effects of point mutations conferring resistance to three major anti-tuberculosis […]

Seminar | Treating 22 million patients for free – lessons learned

Resuscitating primary health care services in Pakistan and integrating vertical (TB) programme service delivery: experiences in setting up a public-private partnership model that has provided free treatment to 22 million patients Dr Riaz Memon is a senior civil servant and head of PPHI Sindh, a public-private partnership which has been contacted to run primary health services for a province […]

IID Seminar | Correlates of risk of TB disease and their back-translation into animal models

Summary Immune correlates of risk of TB disease have recently been identified in human clinical trials. These correlates indicate that, years before TB disease develops, there is alteration in the host-immune environment which is associated with risk of TB disease. Perhaps these alterations render the immune environment permissive to mycobacterial infection or increased growth, or […]

Post-viva seminar | The development of a mathematical modelling framework to translate TB vaccine responses between species and predict the most immunogenic dose in humans using animal data

Summary Vaccine dosing decision making employs relatively antiquated methods compared to the methods employed for drug dosing decision making. As such, we may be discarding vaccine candidates and wasting considerable resources. This failure to use modern methods may, in part, be due to the complexities in measuring a biomarker of vaccine efficacy and defining the […]

Seminar | Latent Tuberculosis Infection: Advances and Challenges

Summary Dr. Sterling received his medical degree from the Columbia University College of Physicians Surgeons, completed his residency training in internal medicine at Columbia-Presbyterian Medical Center, and fellowship training in infectious diseases at Johns Hopkins Hospital. He joined the Johns Hopkins faculty in 1998, and moved to Vanderbilt in 2003. He is the director of […]

Inaugural lecture | Medicinal Maths: a career modelling bugs

Details Speaker: Professor Richard White, Professor of Infectious Disease Modelling Date: Thursday 9 November 2017 Time: 17:15 – 19:00 Venue: Manson Lecture Theatre, Keppel Street Followed by a drinks reception in the North Courtyard Atrium. The lecture will be streamed live. Free and open to all. No registration is required. Entrance is on a first come, first serve […]

ITD Seminar | Why does BCG protect against tuberculosis… and why does it not?

Summary BCG vaccination often fails to protect against TB, hence the need for a new TB vaccine. But sometimes it works. What’s going on, immunologically, in both cases and how can this information help us develop a better vaccine? Details Speaker: Dr Steven Smith, LSHTM Date: 8 November 2017 Time: 12.30 pm Venue: Lucas Room – LG81 Watch […]

Seminar | Financial hardship from drug resistant tuberculosis in Rio de Janeiro, Brazil; A patient cost survey

Summary Even though tuberculosis (TB) diagnosis and treatment is free, households affected by drug resistant (DR) TB incur hidden costs from direct “out of pocket” expenses for consultations, transport, additional food and natural remedies, as well as lost income from personal and family members’ time away from work. The global TB strategy prioritises protecting all […]